We also found a higher BMI and FPG among participants with T2DM with an inverse relationship with PON1 suggesting that participants with a poorer clinical state have poorer anti-inflammatory and antiatherogenic tendencies. This evidence concerns the gene PON1 and type 2 diabetes mellitus.